Mitochondrial permeability transition pore and postconditioning

Cardiovascular Research

Volumn 70, Issue 2, 2006, Pages 264-273

  Gateau Roesch, Odile ^a,b   Argaud, Laurent ^a,b   Ovize, Michel ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b LOUIS PRADEL HOSPITAL   (France)

Author keywords

Ischemia; Mitochondria; Reperfusion

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYCLOPHILIN A; CYCLOSPORIN A; CYCLOSPORIN DERIVATIVE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE INHIBITOR; NIM 811; REACTIVE OXYGEN METABOLITE; SANGHLIFERIN A; UNCLASSIFIED DRUG;

ALKALINIZATION; ANTIINFLAMMATORY ACTIVITY; CONDITIONING; DOG; HEART; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PERMEABILITY; PRIORITY JOURNAL; RABBIT; RAT STRAIN; REOXYGENATION; REPERFUSION; REPERFUSION INJURY; REVIEW; SWINE; TRANSGENICS;

ANIMALS; HUMANS; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY;

EID: 33646030955     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.02.024     Document Type: Review

References (77)

1. McGovern P.G., Pankow J.S., Shahar E., Doliszny K.M., Folsom A.R., Blackburn H., et al. Recent trials in acute coronary disease: mortality, morbidity, medical care and risk factors: the Minnesota Heart Survey investigators. N Engl J Med 334 (1996) 884-890
2. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction and improved survival. Should the paradigm be expanded?. Circulation 79 (1989) 441-444
3. Fibrinolytic Therapy Trialists' (FTT), and Collaborative group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1,000 patients. Lancet 343 (1994) 311-322
4. Braunwald E., and Kloner R.A. Myocardial reperfusion: a double-edged sword?. J Clin Invest 76 (1985) 1713-1719
5. Heyndricks G.R., Millard R.W., McRitchie R.J., Maroko P.R., and Vatner S.F. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 56 (1975) 978-985
6. Braunwald E., and Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66 (1982) 1146-1149
7. Bolli R. Mechanism of myocardial "stunning". Circulation 82 (1990) 723-738
8. Kloner R.A., Ganote C.E., and Jennings R.B. The "no-reflow" phenomenon following temporary coronary occlusion in the dog. J Clin Invest 54 (1974) 1496-1508
9. Ambrosio G., Weisman H.F., and Becker L.C. The "no-reflow" phenomenon: a misnomer?. Circulation 74 suppl II (1986) II-260
10. Kloner R.A. Does reperfusion injury exist in humans. J Am Coll Cardiol 21 (1993) 537-545
11. Hearse D.J. Reperfusion of ischemic myocardium. J Mol Cell Cardiol 9 (1977) 605-616
12. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579-H588
13. Tsang A., Hausenloy D.J., Mocanu M.M., and Yellon D.M. Postconditioning: a form of modified reperfusion protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95 (2004) 230-232
14. Bopassa J.C., Michel P., Gateau-Roesch O., Ovize M., and Ferrera R. Low pressure reperfusion alters mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 288 (2005) H2750-H2755
15. Kin H., Zhao Z.Q., Sun H.Y., Wang N.P., Corvera J.S., Halkos M.E., et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62 (2004) 74-85
16. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44 (2004) 1103-1110
17. Gottlieb R.A., and Engler R.L. Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci 874 (1999) 412-426
18. Matsumura K., Jeremy R.W., Schaper J., and Becker L.C. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 97 (1998) 795-804
19. Piper H.M., Abdallah Y., and Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61 (2004) 365-371
20. Piper H.M., Meuter K., and Schafer C. Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 75 (2003) S644-S648
21. Piper H.M., Garcia-Dorado D., and Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 38 (1998) 291-300
22. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 (1999) 233-249
23. Halestrap A.P., McStay G.P., and Clarke S.J. The permeability transition pore complex: another view. Biochimie 84 (2002) 153-166
24. Halestrap A.P., and Brenner C. The Adenine Nucleotide Translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 10 (2003) 1507-1525
25. Bernardi P., and Petronelli V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J Bioenerg Biomembr 28 (1996) 129-136
26. Zoratti M., and Szabò I. The mitochondrial permeability transition. Biochim Biophys Acta 1241 (1995) 139-176
27. Kroemer G., Dallaporta B., and Resche-Rignon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60 (1998) 619-642
28. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 61 (2004) 372-385
29. DiLisa F., Canton M., Menabo R., Dodoni G., and Bernardi P. Mitochondria and reperfusion injury. The role of permeability transition. Basic Res Cardiol 98 (2003) 235-241
30. Lemasters J.J. The mitochondrial permeability transition and the calcium, oxygen and pH paradoxes: one paradox after another. Cardiovasc Res 44 (1999) 470-473
31. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., and Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192 (2000) 1001-1114
32. Akao M., O'Rourke B., Teshima Y., Seharaseyon J., and Marban E. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ Res 92 (2003) 186-194
33. DiLisa F., Menabo R., Canton M., Barile M., and Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD(+) and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276 (2001) 2571-2575
34. Griffiths E.J., and Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307 (1995) 93-98
35. Woodfield K., Ruck A., Brdiczka D., and Halestrap A.P. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 336 (1998) 287-290
36. Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 529 Pt 1 (2000) 11-21
37. Basso, E, Fante, L, Fowlkes, J, Petronilli, V, Forte, MA, Bernardi, P. Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. JBC 2005 (in press; Published on March 25, 2005 as Manuscript C500089200.
38. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi, Otsu K., Yamagata H., et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434 (2005) 652-657
39. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434 (2005) 658-662
40. Halestrap A.J. A pore way to die. Nature 434 (2005) 578-579
41. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cal J., Jones D.P., et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427 (2004) 461-465
42. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61 (2004) 448-460
43. Tong H., Chen W., Steenbergen C., and Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 87 4 (2000) 309-315
44. Bell R.M., and Yellon D.M. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol 35 (2003) 185-193
45. Yang X.M., Krieg T., Cui L., Downey J.M., and Cohen M.V. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 36 (2004) 411-421
46. Hausenloy D.J., Maddock H.L., Baxter G.F., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovas Res 55 (2002) 534-543
47. Tsang A., Hausenloy D.J., and Yellon D.M. Myocardial postconditioning: reperfusion injury revisited. Am J Physiol - Heart 289 (2005) 2-7
48. Hausenloy D.J., Wynne A., Duchen M., and Yellon. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109 (2004) 1714-1717
49. Javadov S.A., Clarke S., Das M., Griffiths E.J., Lim K.H., and Halestrap A.P. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549 (2003) 513-524
50. 2+-induced mitochondrial permeability transition. Cardiovasc Res 61 (2004) 115-122
51. Galagudza M., Kurapeev D., Minasiana S., Valen G., and Vaage J. Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur J Cardiothorac Surg 25 (2004) 1006-1010
52. Halkos M.E., Kerendi F., Corvera J.S., Wang N.P., Kin H., Payne C.S., et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 78 (2004) 961-969
53. Schwartz L.M., and Lagranha C.J. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol 0290 (2006) H1011-H1018
54. Pasdois P., Labrousse L., Beauvoit B., Bonoron-Adèle S., and Dos Santos P. J Mol Cell Cardiol 38 (2005) 997-1094 [ISHR European Section meeting; abstract 052]
55. Sun K., Liu Z.S., and Sun Q. Role of mitochondria in cell apoptosis during hepatic ischemia reperfusion injury and protective effect of ischemic postconditioning. World J Gastroenterol 10 (2004) 1934-1938
56. 2+ overload. Am J Physiol Heart Circ Physiol 288 (2005) H1900-H1908
57. Buckberg G.D. Studies of controlled reperfusion after ischemia: I. When is cardiac muscle damaged irreversibly?. J Thorac Cardiovasc Surg 92 (1986) 483-487
58. Beyersdorf F., Sarai K., Maul F.D., Wendt T., and Satter P. Immediate functional benefits after controlled reperfusion during surgical revascularization for acute coronary occlusion. J Thorac Cardiovasc Surg 102 (1991) 856-866
59. Hori M., Kitakaze M., Sato H., Takashima S., Iwakura K., Inoue M., et al. Staged reperfusion attenuates myocardial stunning in dogs. Role of transient acidosis during early reperfusion. Circulation 84 (1991) 2135-2145
60. Klawitter P.F., Murray H.N., Clanton T.L., Palmer B.S., and Angelos M.G. Low flow after global ischemia to improve postischemic myocardial function and bioenergetics. Crit Care Med 30 (2002) 2542-2547
61. Heusch G. Postconditioning: old wine in a new bottle?. J Am Coll Cardiol 44 (2004) 1111-1112
62. Argaud L., Gateau-Roesch O., Raisky O., Loufouat J., Robert D., and Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111 (2005) 194-197
63. Ichas F., Jouaville L.S., Sidash S.S., Mazat J.P., and Holmuhamedov E.L. Mitochondrial calcium spiking: a transduction mechanism based on calcium-induced permeability transition involved in cell calcium signalling. FEBS Lett 348 (1994) 211-215
64. Argaud L., Gateau-Roesch O., Muntean D., Chalabreysse L., Loufouat J., Robert D., et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 38 (2005) 367-374
65. Yang C.W., Ahn H.J., Jung J.Y., Kim W.Y., Li C., Choi Bs., et al. Preconditioning with cyclosporin A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. Transplantation 75 (2003) 20-24
66. Yang C.W., Ahn H.J., Han H.J., Kim W.Y., Li C., Shin M.J., et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation 72 (2001) 1753-1759
67. Rezzani R., Rodella L., Dessy C., Daneau G., Bianchi R., and Feron O. Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium. FEBS Lett 552 (2003) 125-129
68. Bopassa J.C., Ferrera R., Gateau-Roesch O., Couture-Lepetit E., and Ovize M. PI3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 69 (2006) 178-185
69. Serviddio G., DiVenosa N., Federici A., D'agostino D., Rollo T., Prigigallo F., et al. Brief hypoxia before normoxic (postconditioning) reperfusion protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J 19 (2005) 354-361
70. Chiari P.C., Bienengraeber M.W., Pagel P.S., Krolikowski J.G., Kersten J.R., and Warltier D.C. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 102 (2005) 102-109
71. Piriou V., Chiari P., Gateau-Roesch O., Argaud L., Muntean D., Salles D., et al. Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology 100 (2004) 581-588
72. Preckel B., Schlack W., Comfere T., Obal D., Barthel H., and Thamer V. Effects of enflurane, isoflurane, sevoflurane, and desflurane on myocardial reperfusion injury after regional myocardial ischemia in the rabbit heart in vivo. Br J Anaesth 81 (1998) 905-912
73. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., et al. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113 (2004) 1535-1549
74. Tong H., Imahashi K., Steenbergen C., and Murphy E. Phosphorylation of glycogen synthase kinase 3β during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res 90 (2002) 377-379
75. Gross E.R., Hsu A.K., and Gross G.J. Opioid-induced cardioprotection occurs via glycogen synthase kinase β inhibition during reperfusion in intact rat hearts. Circ Res 94 (2004) 960-966
76. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'Huillier I., et al. Postconditioning the human heart. Circulation 112 (2005) 2143-2148
77. Tang X.L., Sato H., Tiwari S., Dawn B., Bi Q., Shirk A., et al. Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions < 45 minutes. Circulation 112 (2005) II-309 (abstract 1555)